Waverley Pharma Inc (WAVE : TSX-V)
Common Stock
$0.01
CAD
+0.00 (50.00%)
Last updated: 2026-07-24
Get WAVE alerts:
WAVE
Waverley Pharma Inc
WealthAwesomePerformance
1 Day
+50.00%
1 Week
-40.00%
1 Month
-40.00%
YTD
-40.00%
Key Statistics
Market Cap
$810,000
52W High
$0.03
52W Low
$0.01
P/E Ratio
-
50 Day MA
$0.02
200 Day MA
$0.02
Beta
1.15
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/24/2026 | $0.02 | $0.02 | $0.01 | $0.01 | $0.01 | 7,500 |
| 7/21/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 24,000 |
| 7/3/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 0 |
| 6/23/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 1,730 |
| 6/22/2026 | $0.03 | $0.03 | $0.03 | $0.03 | $0.03 | 2,500 |
| 6/8/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 7,456 |
| 5/28/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 2,000 |
| 5/25/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 5/20/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/17/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 20,000 |
Analyst Price Targets
Based on analyst covering WAVE
Wall Street analysts forecast WAVE stock price to rise 66566.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$10.00
+66566.7% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WAVE's historical volatility
30-Day Vol
504.4%
Annualized
90-Day Vol
525.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.00 – C$0.09 |
| 60 trading days | C$0.02 | C$0.00 – C$0.20 |
| 90 trading days | C$0.02 | C$0.00 – C$0.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Waverley Pharma Inc
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops PARP-1 Inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. In addition, it is involved in the sale of prescription medications, over-the-counter products, and associated pharmacy services. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Financials
- Revenue (TTM)
- $1.25M
- EBITDA
- $-395,644
- Profit Margin
- -50.47%
- ROE (TTM)
- -136.53%
- EPS (Diluted)
- -0.01
- Book Value
- -0.05
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About WAVE
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| KOVO | Kovo Healthtech Corp | $0.01 | +100.00% |
| TBIX | TrustBIX Inc | $0.01 | +100.00% |
| GZD | Grizzly Discoveries Inc | $0.07 | +66.67% |
| TTGI | Turnium Technology Group Inc. | $0.06 | +57.14% |
| SA-H | Southern Arc Minerals Inc | $0.07 | +55.56% |
| PURO | Platauro Metals Corp. | $0.32 | +52.38% |
| ADAD-P | Adagio 2 Capital Inc. | $0.18 | +44.00% |
| JSPX | JasperX Technologies Inc. | $0.07 | +36.36% |
Latest coverage of WAVE.V
Most recent articles mentioning this ticker